"I wanted to know what kind of mutation I had, because I wanted to pay attention to the research.”

In this episode of the Parkinson’s Life podcast, we’re exploring the world of genetics, the role it plays in Parkinson’s, and how research in this area could transform the future of care for everyone with the condition.

Genetics is emerging as one of the most promising areas of research, offering new insights into both the causes of Parkinson’s and potential treatments.

During the episode, we meet Rita, a 42-year-old jewellery designer in Porto, who tells us about her Parkinson’s journey, and why she chose to have her genetics tested.

We also meet two people who are at the forefront of the latest genetics research.

David Dexter, Director of Research at Parkinson's UK, discusses the groundbreaking Landmark Trial, which will use donated brain tissue to unlock the secrets of genetic risk factors.

J Solle, from the Michael J Fox Foundation, introduces us to GP2, an ambitious global programme designed to address the lack of diverse representation in genetic research: "If you do not look in all ancestries, you're simply going to miss something.”

Meet your hosts: 

Amelia Hursey is Strategic Director at Parkinson’s Europe. She has a master’s in cognitive neuropsychology and has been involved in the neurodegenerative research world for 15 years.

Anthony Zahra is a broadcaster and journalist with more than 20 years’ experience in radio, digital and podcasting.

For the latest research and information on Parkinson’s, visit the Parkinson’s Europe website.

If you like what you’ve heard, please rate and review – it helps make sure others can find us. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

“What we wanted was for people to come together. If it achieves better awareness and better treatment, then I think we've done our job.”

As the Parkinson’s Life podcast marks World Parkinson’s Day 2025, we meet Lizzie Graham, co-founder of Parkinson's Europe and our former Secretary General.

Lizzie was one of the key driving forces behind the creation of Parkinson’s Europe, then called the European Parkinson’s Disease Association (EPDA), back in the early 1990s.

She was also instrumental in launching the very first World Parkinson’s Day in 1997, recalling how they gained support from the likes of Princess Diana, Muhammad Ali, and Pope John Paul II.

We also meet Jessie Duncan, European Outreach and Engagement Manager at Parkinson's Europe, who tells us what’s happening across Europe to mark World Parkinson’s Day.

Meet your hosts: 

Amelia Hersey is Strategic Director at Parkinson's Europe. She has a master's in cognitive neuropsychology and has been involved in the neurodegenerative research world for 15 years.

Anthony Zahra is a broadcaster and journalist with more than 20 years’ experience in radio, digital and podcasting.

For the latest research and information on Parkinson’s, visit the Parkinson's Europe website.

If you like what you’ve heard, please rate and review – it helps make sure others can find us. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

What are disease modifying therapies (DMTs) and what impact could they have for people living with Parkinson’s?

In this episode, we delve into the evolving world of DMTs, exploring their potential to slow, halt, or even reverse the progression of Parkinson's, and the challenges involved in bringing these therapies to fruition.

We hear from Philippe, who shares his personal journey with the condition and his thoughts on what it means to slow its progression.

Joining him is Kate Trenam, a Senior Director at the global biopharma company UCB, who provides expert insights into current research, global collaboration efforts, and how DMTs could one day change the way Parkinson’s is treated.

We explore the challenges of measuring the effectiveness of DMTs, the importance of global representation in clinical studies, and why continued patient participation in research is critical to progress.

Meet your hosts: 

Amelia Hersey is Research Manager at Parkinson's Europe. She has a master's in cognitive neuropsychology and has been involved in the neurodegenerative research world for 15 years.

Anthony Zahra is a broadcaster and journalist with more than 20 years’ experience in radio, digital and podcasting.

For the latest research and information on Parkinson’s, visit the Parkinson's Europe website.

If you like what you’ve heard, please rate and review – it helps make sure others can find us. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we explore deep brain stimulation (DBS) and the impact it can have on people with Parkinson’s.

Gerlach Roomans was diagnosed in 2009 and decided to have a DBS procedure after a discussion with his neurologist.

He describes how he felt in the lead up to the operation, the experience of DBS itself, and how it has affected his life since.

He is joined by Lucy Partington-Smith, a DBS and advanced therapy nurse specialist in Manchester in the UK.

And Veerle Visser-Vandewalle, a neurosurgeon and Head of the Department of Stereotactic and Functional Neurosurgery at the University of Cologne.

Together, they discuss all aspects of DBS from how it is decided whether it is suitable for a patient, the risks associated, some of the potential side effects, and the ongoing support that is provided after the initial surgery.

For the latest research and information on Parkinson’s, visit the Parkinson's Europe website.

If you like what you’ve heard, please rate and review – it helps make sure others can find us. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we look at the role that technology can play in supporting people with Parkinson’s.  

UK-based Elaine Payne shares how she uses digital devices to help manage her Parkinson’s symptoms – and why she encourages those with the condition to connect with others in the community. 

She talks to Dr Alistair Mackett, a consultant geriatrician at Addenbrooke’s Hospital in Cambridge, UK, who sheds light on some of the tools and resources available. 

Joining them is Lucy Jung, CEO of technology company Charco Neurotech, who highlights the impact that digital support can have for both clinicians and people with Parkinson’s. 

Together, our guests explore the challenges and opportunities of implementing technology into management strategies – and look at possible future developments in this area. 

This podcast is sponsored by Charco Neurotech, the technology company behind the CUE devices – wearable medical tools designed to support movement in people with Parkinson’s. The episode represents the individual views and experiences of the podcast attendees.  

For the latest research and information on Parkinson’s, visit www.parkinsonseurope.org.

If you like what you’ve heard, please rate and review – it helps make sure others can find us. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we focus on sialorrhea. Also known as drooling, this is a common symptom experienced by people with Parkinson’s.

UK-based David Bateson, who was diagnosed with the condition in 2015, explains how sialorrhea has impacted his speech, working life and interactions with others.

He is joined by Dr Francesca Morgante, a neurologist based at St George’s, University of London – who has been working with David for several years.

Together, the pair tackle key questions around sialorrhea – and share insights on how to manage it.

This podcast has been sponsored by Merz Therapeutics. The content of this episode was up to date and accurate at the time of recording in June 2023. The episode represents the attendees’ own opinions and experiences. This episode has been reviewed by Merz Therapeutics.

Parkinson’s Life magazine is produced by Speak Media on behalf of Parkinson’s Europe, the leading voice for Parkinson’s in Europe. For the latest research and information on Parkinson’s, visit www.parkinsonseurope.org.

If you like what you’ve heard, please rate and review – it helps make sure others can find us. And if you’d like to share your story with Parkinson’s Life magazine, get in touch through Facebook, Twitter or by emailing [email protected]. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

Following our previous episode on what to expect with ‘off’ periods in Parkinson’s, this episode focuses on potential management methods.

Canada-based Barbara Salsberg Mathews, who was diagnosed with the condition in 2020, shares her personal strategies for tackling ‘off’ states and the impact these have had.

She is joined by Dr Silvia Rota, an Italian neurologist and clinical research fellow who sheds light on various treatments and approaches that may be beneficial.

Together, our two guests explore how different tactics can help people to take better control of their ‘off’ periods – and why open communication is key.

This episode was funded by pharmaceutical company Bial. The content of this episode was up to date and accurate at the time of recording in October 2023. The episode represents the individual views and experiences of the podcast attendees.

Parkinson’s Life magazine is produced by Speak Media on behalf of Parkinson’s Europe, the leading voice for Parkinson’s in Europe. For the latest research and information on Parkinson’s, visit www.parkinsonseurope.org.

If you like what you’ve heard, please rate and review – it helps make sure others can find us.

If you’d like to share your story with Parkinson’s Life magazine, get in touch through Facebook, Twitter or by emailing [email protected]. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

In this episode we focus on ‘off’ periods – when Parkinson’s medication is not as effective as it should be, and symptoms become more difficult to manage. 

US-based Bill Bucklew shares how his ‘off’ periods have evolved since he was diagnosed with the condition in 2012, and how they play a role in his daily life. 

Joining him is Dr Valentina Leta, a neurologist based in Italy who highlights the importance of increasing awareness around this important topic. 

Together, our guests explore what people should know about the different types of ‘off’ periods, how to identify them – and how they can impact people in the Parkinson’s community. 

This episode was funded by pharmaceutical company Bial. The content of this episode was up to date and accurate at the time of recording in October 2023. The episode represents the individual views and experiences of the podcast attendees.

Parkinson’s Life magazine is produced by Speak Media on behalf of Parkinson’s Europe, the leading voice for Parkinson’s in Europe. For the latest research and information on Parkinson’s, visit www.parkinsonseurope.org.

If you like what you’ve heard, please rate and review – it helps make sure others can find us.  

If you’d like to share your story with Parkinson’s Life magazine, get in touch through Facebook, Twitter or by emailing [email protected]. Keep a lookout for our next episode and until then, take care!

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we explore gait impairment – a common symptom of Parkinson’s that can involve slowness, muscle stiffness and freezing – and how it impacts people living with the condition.

Our first guest is David Little, who lives in Carlisle, UK. Having previously worked as a firefighter, David was diagnosed with Parkinson’s back in 2005. David has experienced first-hand the effects of gait impairment in his day-to-day life and says he’s keen to challenge the misconceptions that can surround the condition.

He is joined by Martina Mancini from Italy, who works as an assistant professor in the neurology department at the Oregon Health & Sciences University, in Oregon, US. Martina has worked on numerous studies about gait impairment – and has also investigated the role wearable devices can play in treatment.

David and Martina discuss what causes gait impairment, share advice on managing these symptoms – and explore how current research is addressing this topic.

This episode was funded by Charco Neurotech, the ­­company behind CUE1 – a wearable medical device designed to help alleviate gait impairment and support movement in people with Parkinson’s.

Parkinson’s Life magazine is produced by Speak Media on behalf of the European Parkinson’s Disease Association, the leading voice for Parkinson’s in Europe. For the latest research and information on Parkinson’s, visit EPDA.eu.com.

If you like what you’ve heard, please rate and review – it helps make sure others can find us.

And if you’d like to share your story with Parkinson’s Life magazine, get in touch through Facebook, Twitter or by emailing [email protected].

Hosted on Acast. See acast.com/privacy for more information.